# Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension

> **NCT00650702** · PHASE2 · COMPLETED · sponsor: **Mati Therapeutics Inc.** · enrollment: 36 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Latanoprost-PPDS
- **DRUG:** Latanoprost-PPDS
- **DRUG:** Latanoprost-PPDS

## Key facts

- **NCT ID:** NCT00650702
- **Lead sponsor:** Mati Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650702, "Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00650702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*